Cempra (CEMP) Misses Q4 EPS by 1c, to Reduce Workforce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cempra, Inc. (CEMP) PT Lowered to $4 at Stifel; Reiterates Hold
March 1, 2017 8:59 AM ESTStifel lowered its price target on Cempra, Inc. (NASDAQ: CEMP) to $4.00 (from $8.00) while maintaining a Hold rating. GAAP net loss of $31.5M, or $(0.60)/share, was wider than Consensus' $(0.55) estimates.
Analyst Stephen Willey commented, "Incremental solithromycin updates provided on managements 4Q16 earnings announcement/call... More
Cempra (CEMP) Underperform Rating Reiterated at Baird Post Q4
February 28, 2017 12:45 PM ESTJefferies analyst Brian Skorney reiterated his Underperform rating and $2 price target on Cempra, Inc. (NASDAQ: CEMP) following results.
Skorney commented, "Cempra reported in-line earnings in 4Q16, along with a host of trial discontinuations, failure in gonorrhea, and updates on discussions with... More
